Investors flock to $PBIO as its Patent PCT Platform goes
Investors flock to $PBIO as its Patent PCT Platform goes mainstream!
http://bit.ly/1ZwJzao
The information provided above came to you from Uptick Newswire (herein referred to as “us”, “we” or “the website”) is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. All information that we provide is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Furthermore, investing in such securities involves substantial risk of loss and investors should seek advice from financial professionals before investing.
Uptick Newswire provides social media outreach and Investor Relations services for Micro-Cap companies. These are paid services. We may from time to time hold shares of companies featured as payment for services rendered. It is understood that Investing in micro-cap securities is highly speculative and carries an extremely high degree of risk. It is possible that the investor’s entire investment may be lost or impaired due to the speculative nature of the companies listed.
Uptick Newswire makes no recommendation that the securities of the companies listed should be purchased, sold or held by individuals or entities that learn of the listed companies through Uptick Newswire representatives or upticknewswire.com. Any suggestions made by Uptick Newswire staff regarding companies featured on upticknewswire.com is solely that “a suggestion” nothing more. It is our expectation that investors will do their own due diligence.
We recommend that readers use the information found within as a starting point for conducting their own research on the featured company in order to determine their own personal opinion of the company before investing. Uptick Newswire is not liable for any investment decisions made by our readers. Readers should investigate and fully understand all risks before investing.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
St. Luke's University Health Network Introduces New Fellowship St. Luke's University Health Network is excited to announce the launch of its Addiction Psychiatry Fellowship, designed to equip medical professionals to better serve those struggling with addiction. This fellowship represents a significant commitment to improving mental health care and reflects St. Luke's...
Continue Reading
BT Group's Stock Performance Following Court Ruling Shares of BT Group PLC (LSE:LON:BT) experienced a noticeable increase today, rising by 1% after an important ruling from a court. The court dismissed a class action lawsuit that accused the company of overcharging customers for landline services. This ruling marks a significant turning point for the company, alleviating...
Continue Reading
GC Biopharma and Novelty Nobility Forge Joint Research Alliance GC Biopharma has announced an exciting partnership with Novelty Nobility, a company focused on advanced antibody-based therapeutics, aiming to tackle geographic atrophy (GA), a severe complication related to age-related macular degeneration (AMD). AMD is classified into two types: dry and wet. The dry type...
Continue Reading
A Significant Contribution to Affordable Housing The Arbella at Bramble Hill, a notable developer, has made headlines with a generous $100,000 donation to the Worcester Affordable Housing Trust Fund (AHTF). This act is more than just a financial contribution; it represents a commitment to improving the lives of residents in the community. It also marks the AHTF's first...
Continue Reading
Oracle AI Agents Transforming Productivity New specialized AI agents are being introduced within Oracle Fusion Cloud Applications, changing the way work gets done in fields like finance, supply chain, HR, sales, marketing, and service. Recently, Oracle launched over 50 role-based AI agents as part of its Oracle Fusion Cloud Applications Suite. These agents are crafted to...
Continue Reading